Current Assets
Income taxes receivable
Biogen Income taxes receivable decreased by 4.6% to $661.60M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
An increase may indicate overpayment of estimated taxes or the accrual of refundable credits, representing a potential source of near-term cash inflow.
Detailed definition
This represents the amount of income tax overpayments or refundable tax credits that the company expects to recover from...
Peer comparison
Common for large corporations that manage complex tax filings across multiple jurisdictions.
Metric ID:
income_taxes_receivableHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $693.60M | $661.60M |
| QoQ Change | — | -4.6% |
Range$661.60M – $693.60M
Income taxes receivable at Other Companies
Frequently Asked Questions
- What is Biogen's income taxes receivable?
- Biogen (BIIB) reported income taxes receivable of $661.60M in Q1 2026.
- What does income taxes receivable mean?
- Tax refunds or credits owed to the company by government tax agencies.